Of 21 patients with end-stage COVID-19 in China, 6 received convalescent plasma and 15 did not. Nineteen died; 5 of 6 in the convalescent plasma group and 14 of 15 in the control group (p=0.18). One in each group survived. Details and more in this week's Science Summary by Dr. Andrew Mujugira.